Pattern and characteristics of ecstasy and related drug (ERD) presentations at two hospital emergency departments, Melbourne, Australia, 2008-2010

Emergency Medicine Journal

Volumn 31, Issue 4, 2014, Pages 317-322

  Horyniak, Danielle ^a,b   Degenhardt, Louisa ^c,d   Smit, De Villiers ^e   Munir, Venita ^f   Johnston, Jennifer ^g   Fry, Craig ^d,h   Dietze, Paul ^a,b  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e Emergency and Trauma Centre   (Australia)

^f Emergency Department Emergency Practice Innovation Centre St Vincent's Health   (Australia)

^g UNIVERSITY OF SYDNEY   (Australia)

^h VICTORIA UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; AMYL NITRITE; CENTRAL STIMULANT AGENT; COCAINE; ILLICIT DRUG; KETAMINE; LYSERGIDE; METHAMPHETAMINE; METHYLPHENIDATE; NITROUS OXIDE; PSYCHEDELIC AGENT;

ADULT; AMBULANCE; ARTICLE; AUSTRALIA; EMERGENCY CARE; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; ENDOTRACHEAL INTUBATION; FEMALE; HARM REDUCTION; HOSPITAL ADMISSION; HUMAN; INTUBATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIORITY JOURNAL; SUBSTANCE USE; TERTIARY CARE CENTER; TWO TAILED TEST; YOUNG ADULT; DRUG ABUSE; EPIDEMIOLOGY; HOSPITAL; MEDICAL AUDIT; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADULT; AMPHETAMINE-RELATED DISORDERS; CLINICAL AUDIT; EMERGENCY SERVICE, HOSPITAL; FEMALE; HALLUCINOGENS; HOSPITALS, URBAN; HUMANS; LOGISTIC MODELS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; SOUTH AUSTRALIA; YOUNG ADULT;

EID: 84896086446     PISSN: 14720205     EISSN: 14720213     Source Type: Journal    
DOI: 10.1136/emermed-2012-202174     Document Type: Article

References (32)

1. Australian Institute of Health & Welfare. 2010 National Drug Strategy Household Survey Report, Drug Statistics Series No. 25. Canberra: Australian Institute of Health & Welfare, 2011.
2. Sindicich N, Burns L. Australian Trends in Ecstasy and Related Drug Markets 2011: Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2012, Australian Drug Trend Series No. 82.
3. Chen C, Kostakis C, Harpas P, et al. Marked decline in 3,4-methylenedioxymethamphetamine (MDMA) based on wastewater analysis. J Stud Alcohol Drugs 2011;72:737-40.
4. Sweeney J, Macgregor S. Decrease in use of ecstasy/MDMA, Drug Use Monitoring in Australia (DUMA) Report No. 26. Canberra: Australian Institute of Criminology, 2012.
5. Sindicich N, Burns L. Australian Trends in Ecstasy and Related Drug Markets 2010: Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2011, Australian Drug Trend Series No. 83.
6. Degenhardt L, Mathers B, Guarinieri M, et al. Meth/amphetamine use and associated HIV: implications for global policy and public health. Int J Drug Policy 2010;21:347-58.
7. Degenhardt L, Bucello C, Calabria B, et al. What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug Alcohol Depend 2011;117:85-101.
8. Lea T, Reynolds R, de Wit J. Alcohol and club drug use among same-sex attracted young people: associations with frequenting the lesbian and gay scene and other bars and nightclubs. Subst Use Misuse Posted online on November 5, 2012. (doi:10.3109/10826084.2012.733904)
9. Duff C. Party drugs and party people: examining the 'normalization' of recreational drug use in Melbourne, Australia. Int J Drug Policy 2005;16:161-70. (Pubitemid 40800203)
10. Liechti ME, Kunz I, Kupferschmidt H. Acute medical problems due to Ecstasy use. Case-series of emergency department visits. Swiss Med Wkly 2005;135:652-7.
11. Rogers G, Elston J, Garside R, et al. The harmful health effects of recreational ecstasy: a systematic review of observational evidence. Health Technol Assess 2009;13:iii-iv, ix-xii, 1-315.
12. Munir VL, Hutton JE, Harney JP, et al. Gamma-hydroxybutyrate: a 30 month emergency department review. Emerg Med Australas 2008;20:521-30.
13. Sporer KA, Chin RL, Dyer JE, et al. Gamma-hydroxybutyrate serum levels and clinical syndrome after severe overdose. Ann Emerg Med 2003;42:3-8. (Pubitemid 36792277)
14. Liechti ME, Kunz I, Greminger P, et al. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. Drug Alcohol Depend 2006;81:323-6. (Pubitemid 43152459)
15. Galicia M, Nogue S, Miro O. Liquid ecstasy intoxication: clinical features of 505 consecutive emergency department patients. Emerg Med J 2011;28:462-6.
16. Caldicott DG, Chow FY, Burns BJ, et al. Fatalities associated with the use of gamma-hydroxybutyrate and its analogues in Australasia. Med J Aust 2004;181:310-13. (Pubitemid 39302713)
17. Degenhardt L, Darke S, Dillon P. GHB use among Australians: characteristics, use patterns and associated harm. Drug Alcohol Depend 2002;67:89-94. (Pubitemid 34615930)
18. Nicholson KL, Balster RL. GHB: a new and novel drug of abuse. Drug Alcohol Depend 2001;63:1-22. (Pubitemid 32288730)
19. Degenhardt L, Roxburgh A, Black E, et al. The epidemiology of methamphetamine use and harm in Australia. Drug Alcohol Rev 2008;27:243-52.
20. Lloyd B. Trends in alcohol and drug related ambulance attendances in Melbourne: 2009/10. Fitzroy: Turning Point Alcohol and Drug Centre 2011.
21. Lowthian JA, Curtis AJ, Jolley DJ, et al . Demand at the emergency department front door: 10-year trends in presentations. Med J Aust 2012;196:128-32.
22. Couper FJ, Thatcher JE, Logan BK. Suspected GHB overdoses in the emergency department. J Anal Toxicol 2004;28:481-4. (Pubitemid 39150369)
23. de Millas W, Haasen C, Reimer J, et al. Emergencies related to cocaine use: a European multicentre study of expert interviews. Eur J Emerg Med 2010; 17:33-6.
24. Bunting PJ, Fulde GW, Forster SL. Comparison of crystalline methamphetamine ('ice') users and other patients with toxicology-related problems presenting to a hospital emergency department. Med J Aust 2007;187:564-6.
25. Gray SD, Fatovich DM, McCoubrie DL, et al. Amphetamine-related presentations to an inner-city tertiary emergency department: a prospective evaluation. Med J Aust 2007;186:336-9. (Pubitemid 46566858)
26. Indig D, Copeland J, Conigrave KM, et al. Characteristics and comorbidity of drug and alcohol-related emergency department presentations detected by nursing triage text. Addiction 2010;105:897-906.
27. Victorian Government Department of Health. Victorian Health Services Performance: Performance Data by Hospital (17/10/2012). http://performance. health.vic.gov.au/Home/Performance-Data-by-Hospital.aspx (accessed 17 Oct 2012).
28. Richardson DB. Emergency department targets: a watershed for outcomes research? Med J Aust 2012;196:126-7.
29. Zheng W, Muscatello DJ, Chan AC. Deck the halls with rows of trolleys...emergency departments are busiest over the Christmas holiday period. Med J Aust 2007;187:630-3.
30. Akbar T, Baldacchino A, Cecil J, et al. Poly-substance use and related harms: a systematic review of harm reduction strategies implemented in recreational settings. Neurosci Biobehav Rev 2012;35:1186-202.
31. Johnston J, Barratt M, Fry C, et al. A survey of regular ecstasy users' knowledge and practices around determining pill content and purity: implications for policy and practice. Int J Drug Policy 2006;17:464-72. (Pubitemid 44780945)
32. ACON. Drugs at parties: For Guests (19/10/2012). http://www. partyingathome.acon. org.au/index/downloads/PartyingatHomeDrugsforguests.pdf (accessed 19 Oct 2012).